Dr. Wai-Ching Lam
Dr. Wai-Ching Lam is the Head of the Ophthalmology Department of Vancouver General Hospital, and the Medical Director of Ophthalmology of the UBC Hospital
Dr. Lam is a vitreo-retinal surgeon with clinical interests in adult and pediatric retinal diseases. For his clinical and scientific work, he received the Achievement Award from the American Academy of Ophthalmology and Asian Pacific Academy of Ophthalmology, and Fellow and the Senior Honor Award from the American Society of Retinal Specialists.
He is a committed medical educator and won 16 teaching awards in 18 years from the Faculty of Medicine and the Department of Surgery, and Ophthalmology and Vision Sciences while at the University of Toronto.
He has published over 100 peer-reviewed articles. He has also authored 7 book chapters, and recently co-edit a new book, “A Quick Guide Pediatric Retina”, Springer 2021.
Financial disclosure: Dr. Lam has/had an affiliation (financial or otherwise) with a commercial organization:
- Alcon
- Allergan
- Bayer
- Novartis
- Roche
Sessions in which Dr. Wai-Ching Lam participates
Friday 20 June, 2025
Author’s Name(s): Wai-Ching Lam, Timothy Lai, Xiaodong Sun, Shih-Jen Chen, Xin Zhang, Andrea Schulze, Tobias Machewitz, Min Zhao, Sergio LealAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Apellis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Novartis, Membership on an advisory panel, standing committee or board of directors, Amgen, Membership on an advi...
Author’s Name(s): Wai-Ching Lam, Shih-Jen Chen, Gemmy Cheung, Tomohiro Iida, Adrian Koh, Won Ki Lee, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Timothy LaiAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Novartis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Amgen, Membership on an advisory panel, standing committee or board of directors, Apellis, ...
Saturday 21 June, 2025
Learning ObjectivesAt the end of this session, participants will be able to:Understand how the home OCT works and its practical application in the management of retinal diseases.
Sunday 22 June, 2025
Attendees will actively participate during this session, engaging in questions and sharing their diagnoses.